Inve India ▾

Sat Kartar share price & results

Sat Kartar· Healthcare

Results to
Sept 2026
Latest analysed call
Q4 FY26
Ownership as of
Sept 2026

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue106 ₹ crore+20.5% YoYQuarterly, as filedQuarter to Sept 2026Revenue from operations as filed.
Operating margin14.0 %+2.0 pts YoYOperating profit / revenueQuarter to Sept 2026For the quarter; a change is in percentage points.
Net profit9.0 ₹ crore+12.5% YoYQuarterly, as filedQuarter to Sept 2026Profit after tax as filed.
Return on equityUnavailable+7.4 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM · period unavailableNot in the analysed materials. No older figure is substituted.
Free cash flow margin-3.69 %+2.3 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)Unavailable—Trailing twelve monthsTTM · period unavailableNot in the analysed materials. No older figure is substituted.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Sept 2026

Guidance

What management said, and what became of it

2 of 4 judged targets kept · 8 open · verdicts reflect calls analysed to Q4 FY26.

Sat Kartar management guidance track record on Inve: 12 targets tracked across analysed earnings calls (2 achieved, 2 missed, 8 open).

TargetOriginal wordingSaidLatest callVerdict
FY26 Revenue₹230-240 crores (40-50% growth)
Call transcript, Q4 FY25 · 19 May 2025
Q4 FY25Q4 FY26:Revenue crossed the 200 mark, growing 23%. Achieved the revised target but missed the original ₹230-240 cr target.
Call transcript, Q4 FY26 · 7 May 2026
Achieved*
FY26 PAT Margin9-10%
Call transcript, Q4 FY25 · 19 May 2025
Q4 FY25Q4 FY26:Reported PAT of ₹17 crores on ₹200 crores revenue, yielding an 8.5% margin, missing the 9-10% target.
Call transcript, Q4 FY26 · 7 May 2026
Missed
Long-term Revenue₹500 crores top line in three years
Call transcript, Q4 FY25 · 19 May 2025
Q4 FY25Q4 FY26:Reiterated target of crossing ₹500 crores in FY28.
Call transcript, Q4 FY26 · 7 May 2026
On Track

Source: Inve Guidance Tracker for Sat Kartar · to Q4 FY26

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

2 of Sat Kartar's 12 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 9 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹134 +4.08% · +₹5.25

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance −21.2% 1Y

₹120₹140₹160₹180₹200Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q2 FY26 — 31 Oct 2025Q4 FY26 — 7 May 2026

1Y: ₹170.05 on 24 Oct 2025 → ₹134. High ₹205 (23 Apr 2026), low ₹116.05 (7 Sept 2026).

Previous close
₹128.75
Market cap
₹212 Cr
52-week range
₹116.05 – ₹205
One year
−30.10%
Price to earnings (FY ending Mar 2026)
13.25×
Return on equity (FY ending Mar 2026)
26.67%

Overview

Symbol
NSE:SATKARTAR
Exchange
NSE
Currency
INR

How the price took the results

close before → close after

Q4 FY26
−1.9%
7 May
Q2 FY26
−1.6%
1 Nov

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for Sat Kartar

Free account: one company. Everything above stays public.

Write why you follow Sat Kartar and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds